Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 340

    1.

    Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia.

    Koh KK, Han SH, Quon MJ, Yeal Ahn J, Shin EK.

    Diabetes Care. 2005 Jun;28(6):1419-24.PMID: 15920062 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients.

    Koh KK, Quon MJ, Han SH, Chung WJ, Ahn JY, Kim JA, Lee Y, Shin EK.

    Diabetes Care. 2006 Feb;29(2):195-201.PMID: 16443859 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemia.

    Capell WH, DeSouza CA, Poirier P, Bell ML, Stauffer BL, Weil KM, Hernandez TL, Eckel RH.

    Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):307-13.PMID: 12588776 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Amlodipine improves endothelial function and metabolic parameters in patients with hypertension.

    Koh KK, Han SH, Ahn JY, Chung WJ, Lee Y, Shin EK.

    Int J Cardiol. 2009 Mar 20;133(1):23-31. Epub 2008 Jan 15.PMID: 18199500 [PubMed - indexed for MEDLINE]Related articles

    5.

    Simvastatin improves flow-mediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients.

    Koh KK, Quon MJ, Han SH, Lee Y, Ahn JY, Kim SJ, Koh Y, Shin EK.

    Diabetes Care. 2008 Apr;31(4):776-82. Epub 2008 Jan 9.PMID: 18184901 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome.

    Rosenson RS, Wolff DA, Huskin AL, Helenowski IB, Rademaker AW.

    Diabetes Care. 2007 Aug;30(8):1945-51. Epub 2007 May 4.PMID: 17483155 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effects of fenofibrate on lipoproteins, vasomotor function, and serological markers of inflammation, plaque stabilization, and hemostasis.

    Kon Koh K, Yeal Ahn J, Hwan Han S, Kyu Jin D, Sik Kim H, Cheon Lee K, Kyun Shin E, Sakuma I.

    Atherosclerosis. 2004 Jun;174(2):379-83.PMID: 15136070 [PubMed - indexed for MEDLINE]Related articles

    9.

    Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles.

    Wang TD, Chen WJ, Lin JW, Cheng CC, Chen MF, Lee YT.

    Atherosclerosis. 2003 Oct;170(2):315-23.PMID: 14612213 [PubMed - indexed for MEDLINE]Related articles

    10.

    Anti-inflammatory and metabolic effects of candesartan in hypertensive patients.

    Koh KK, Quon MJ, Han SH, Chung WJ, Lee Y, Shin EK.

    Int J Cardiol. 2006 Mar 22;108(1):96-100. Epub 2005 Oct 24.PMID: 16246439 [PubMed - indexed for MEDLINE]Related articles

    11.

    Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia.

    Koh KK, Quon MJ, Han SH, Chung WJ, Ahn JY, Seo YH, Choi IS, Shin EK.

    J Am Coll Cardiol. 2005 May 17;45(10):1649-53.PMID: 15893182 [PubMed - indexed for MEDLINE]Related articles

    12.

    Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.

    Watts GF, Barrett PH, Ji J, Serone AP, Chan DC, Croft KD, Loehrer F, Johnson AG.

    Diabetes. 2003 Mar;52(3):803-11.PMID: 12606523 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT).

    Malik J, Melenovsky V, Wichterle D, Haas T, Simek J, Ceska R, Hradec J.

    Cardiovasc Res. 2001 Nov;52(2):290-8.PMID: 11684077 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome.

    Rosenson RS.

    Am Heart J. 2008 Mar;155(3):499.e9-16. Epub 2008 Jan 31.PMID: 18294485 [PubMed - indexed for MEDLINE]Related articles

    15.

    Low adiponectin levels in primary hypertriglyceridemic male patients.

    Gómez Rosso L, Meroño T, Benítez MB, López G, Giunta G, D'Ambrosio ML, Wikinski R, Cuniberti L, Brites F.

    Nutr Metab Cardiovasc Dis. 2009 Feb;19(2):135-9. Epub 2008 May 9.PMID: 18472252 [PubMed - indexed for MEDLINE]Related articles

    16.

    Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes.

    Martens FM, Visseren FL, de Koning EJ, Rabelink TJ.

    J Cardiovasc Pharmacol. 2005 Dec;46(6):773-8.PMID: 16306801 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients.

    Gannagé-Yared MH, Azar RR, Amm-Azar M, Khalifé S, Germanos-Haddad M, Neemtallah R, Halaby G.

    Metabolism. 2005 Jul;54(7):947-51.PMID: 15988706 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients.

    Rosenson RS.

    Obesity (Silver Spring). 2009 Mar;17(3):504-9. Epub 2008 Nov 20.PMID: 19023279 [PubMed - indexed for MEDLINE]Related articles

    19.

    Fenofibrate of gemfibrozil for treatment of types IIa and IIb primary hyperlipoproteinemia: a randomized, double-blind, crossover study.

    Insua A, Massari F, Rodríguez Moncalvo JJ, Rubén Zanchetta J, Insua AM.

    Endocr Pract. 2002 Mar-Apr;8(2):96-101.PMID: 11942772 [PubMed - indexed for MEDLINE]Related articles

    20.

    Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome.

    Rosenson RS, Huskin AL, Wolff DA, Helenowski IB, Rademaker AW.

    Atherosclerosis. 2008 Jun;198(2):381-8. Epub 2008 Feb 1.PMID: 18242616 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data